Stay updated on OV101 in Fragile X Syndrome: Clinical Trial
Sign up to get notified when there's something new on the OV101 in Fragile X Syndrome: Clinical Trial page.

Latest updates to the OV101 in Fragile X Syndrome: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedAdded a dedicated Locations section listing site locations (California, Colorado, Illinois, Maryland, Ohio, Tennessee) and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the prior state-location entries.SummaryDifference0.8%

- Check16 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedPublication section now clarifies that entries are automatically filled from PubMed. Revision number updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding/operating status notice has been removed from the page, reducing site-wide status messaging. This is a minor, non-study-related update.SummaryDifference0.4%

- Check60 days agoChange DetectedResults section added with study outcomes (TEAEs and CGI-I) and updated posting dates.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference6%

- Check89 days agoChange DetectedUpdated terminology to 'Fragile X syndrome' and bumped version to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to OV101 in Fragile X Syndrome: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OV101 in Fragile X Syndrome: Clinical Trial page.